45 related articles for article (PubMed ID: 29193067)
1. Kainate and AMPA receptors in epilepsy: Cell biology, signalling pathways and possible crosstalk.
Henley JM; Nair JD; Seager R; Yucel BP; Woodhall G; Henley BS; Talandyte K; Needs HI; Wilkinson KA
Neuropharmacology; 2021 Sep; 195():108569. PubMed ID: 33915142
[TBL] [Abstract][Full Text] [Related]
2. Activation and Denitrosylation of Procaspase-3 in KA-induced Excitotoxicity.
Liu Y; Yan H; Zhang J; Cai YT; Yin XH; Lu F; Liu YK; Li C
Protein Pept Lett; 2023; 30(10):854-867. PubMed ID: 37921157
[TBL] [Abstract][Full Text] [Related]
3. The kainate receptor GluK2 mediates cold sensing in mice.
Cai W; Zhang W; Zheng Q; Hor CC; Pan T; Fatima M; Dong X; Duan B; Xu XZS
Nat Neurosci; 2024 Apr; 27(4):679-688. PubMed ID: 38467901
[TBL] [Abstract][Full Text] [Related]
4. The positive allosteric modulator BPAM344 and L-glutamate introduce an active-like structure of the ligand-binding domain of GluK2.
Bay Y; Egeberg Jeppesen M; Frydenvang K; Francotte P; Pirotte B; Pickering DS; Kristensen AS; Kastrup JS
FEBS Lett; 2024 Apr; 598(7):743-757. PubMed ID: 38369668
[TBL] [Abstract][Full Text] [Related]
5. JNK activity modulates postsynaptic scaffold protein SAP102 and kainate receptor dynamics in dendritic spines.
Kunde SA; Schmerl B; von Sivers J; Ahmadyar E; Gupta T; Rademacher N; Zieger HL; Shoichet SA
J Biol Chem; 2024 May; 300(5):107263. PubMed ID: 38582451
[TBL] [Abstract][Full Text] [Related]
6. Positive and negative allosteric modulation of GluK2 kainate receptors by BPAM344 and antiepileptic perampanel.
Gangwar SP; Yen LY; Yelshanskaya MV; Sobolevsky AI
Cell Rep; 2023 Feb; 42(2):112124. PubMed ID: 36857176
[TBL] [Abstract][Full Text] [Related]
7. Reversing Aging: Decline in Complex Olfactory Learning Can be Rectified by Restoring Intrinsic Plasticity of Hippocampal CA1 Pyramidal Neurons.
Awasthi R; Yuan Q; Barkai E
Adv Biol (Weinh); 2024 Mar; 8(3):e2300323. PubMed ID: 38145360
[TBL] [Abstract][Full Text] [Related]
8. S-nitrosylation of E3 ubiquitin-protein ligase RNF213 alters non-canonical Wnt/Ca+2 signaling in the P301S mouse model of tauopathy.
Amal H; Gong G; Gjoneska E; Lewis SM; Wishnok JS; Tsai LH; Tannenbaum SR
Transl Psychiatry; 2019 Jan; 9(1):44. PubMed ID: 30696811
[TBL] [Abstract][Full Text] [Related]
9. The atypical 'hippocampal' glutamate receptor coupled to phospholipase D that controls stretch-sensitivity in primary mechanosensory nerve endings is homomeric purely metabotropic GluK2.
Thompson KJ; Watson S; Zanato C; Dall'Angelo S; De Nooij JC; Pace-Bonello B; Shenton FC; Sanger HE; Heinz BA; Broad LM; Grosjean N; McQuillian JR; Dubini M; Pyner S; Greig I; Zanda M; Bleakman D; Banks RW; Bewick GS
Exp Physiol; 2024 Jan; 109(1):81-99. PubMed ID: 37656490
[TBL] [Abstract][Full Text] [Related]
10. Coordinated interplay between palmitoylation, phosphorylation and SUMOylation regulates kainate receptor surface expression.
Yucel BP; Al Momany EM; Evans AJ; Seager R; Wilkinson KA; Henley JM
Front Mol Neurosci; 2023; 16():1270849. PubMed ID: 37868810
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic and non-enzymatic transnitrosylation: "SCAN"ning the SNO-proteome.
Nakamura T; Lipton SA
Mol Cell; 2024 Jan; 84(2):191-193. PubMed ID: 38242098
[TBL] [Abstract][Full Text] [Related]
12. 'NO-how' enzymatic S-nitrosylation controls insulin pathophysiology.
Filomeni G
Trends Endocrinol Metab; 2024 Feb; ():. PubMed ID: 38587367
[TBL] [Abstract][Full Text] [Related]
13. Neuronal Nitric Oxide Synthase and Post-Translational Modifications in the Development of Central Nervous System Diseases: Implications and Regulation.
Maccallini C; Amoroso R
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764469
[TBL] [Abstract][Full Text] [Related]
14. H19 silencing decreases kainic acid-induced hippocampus neuron injury via activating the PI3K/AKT pathway via the H19/miR-206 axis.
Ju H; Yang Z
Exp Brain Res; 2022 Aug; 240(7-8):2109-2120. PubMed ID: 35781830
[TBL] [Abstract][Full Text] [Related]
15. Nitrosative Stress and Human Disease: Therapeutic Potential of Denitrosylation.
Yoon S; Eom GH; Kang G
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575960
[TBL] [Abstract][Full Text] [Related]
16. Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy.
Celli R; Fornai F
Curr Neuropharmacol; 2021; 19(6):747-765. PubMed ID: 32867642
[TBL] [Abstract][Full Text] [Related]
17. The role of S-nitrosylation of kainate-type of ionotropic glutamate receptor 2 in epilepsy induced by kainic acid.
Wang L; Liu Y; Lu R; Dong G; Chen X; Yun W; Zhou X
J Neurochem; 2018 Feb; 144(3):255-270. PubMed ID: 29193067
[TBL] [Abstract][Full Text] [Related]
18. Coupling between neuronal nitric oxide synthase and glutamate receptor 6-mediated c-Jun N-terminal kinase signaling pathway via S-nitrosylation contributes to ischemia neuronal death.
Yu HM; Xu J; Li C; Zhou C; Zhang F; Han D; Zhang GY
Neuroscience; 2008 Sep; 155(4):1120-32. PubMed ID: 18676085
[TBL] [Abstract][Full Text] [Related]
19. nNOS downregulation attenuates neuronal apoptosis by inhibiting nNOS-GluR6 interaction and GluR6 nitrosylation in cerebral ischemic reperfusion.
Di JH; Li C; Yu HM; Zheng JN; Zhang GY
Biochem Biophys Res Commun; 2012 Apr; 420(3):594-9. PubMed ID: 22445759
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
